Why did Medtronic stock rise on 8 October?
Written after the close on
Medtronic +2.62%
Medtronic rose sharply, helped by its MiniMed split-off terms. Medtronic rose slightly over the last five trading days, in line with a clearly higher S&P 500 and a slightly higher healthcare sector, with the sharp last-session gain standing out against a slightly weaker market and sector. The likely driver was the final exchange ratio for its MiniMed diabetes-business split-off — the share swap letting investors trade Medtronic stock for MiniMed stock — plus a new cardiac ablation leader and permanent billing codes for two devices, all steps that make the diabetes separation and its heart-device pipeline look more concrete. Watch the mid-November earnings report, where management's fiscal 2027 guidance and cardiac ablation growth will matter most.
Next report: · Add to calendar · Google Calendar